doctia glp 1 Considering GLP-1 drugs for weight loss? Advice from a doctor who's used them : NPR How GLP-1 medications are transforming

MK-677 (Ibutamoren) MK-677 (ibutamoren) is an orally active, non-peptide small molecule agonist of the ghrelin receptor (GHSR-1a) that stimulates endogenous growth hormone and IGF-1 secretion, studied in randomized trials in older adults, obesity, and sleep research

Is KB Rosehips safe for daily use

Semaglutide is studied as a GLP-1 receptor-focused peptide in metabolic research models

Later on, I found out, this was 2011 [00:14:00] University of Texas in Austin did a study on the liposome technology product of glirathione

This slowing contributes to the appetite suppression that drives weight loss and the postprandial glucose-lowering effect, and it also drives most of the gastrointestinal side effect profile.[1],[2] A 2025 review in the Journal of Clinical Endocrinology & Metabolism summarizes the published evidence: GLP-1 receptor agonists impact gastric, intestinal, and gallbladder motility simultaneously, with effects on gastric fundus relaxation, antral contractility inhibition, increased pyloric tone, and reduced small intestinal motility.[3] The path from this mechanism to constipation is straightforward